Parse

Parse indexes AI recommendations so brands know where they stand.

Products

  • Brands
  • Markets
  • Integrations
  • Work with us
  • Pricing
  • MCP

Resources

  • Research
  • Methodology
  • Blog

© 2026 Parse. All rights reserved.

LegalPrivacy PolicyTerms of Service
Parse
Work with usPricing
Sign inCheck your brand
  1. Brands
  2. CHARM Therapeutics
BrandsCHARM Therapeutics

How AI describes CHARM Therapeutics

Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this

CHARM Therapeutics logoCHARM Therapeuticscharmtx.com

CHARM Therapeutics is developing next-generation menin inhibitors designed to address resistance seen with first-generation approaches in treating Acute Myeloid Leukemia. By targeting the menin-KMT2A interface, their structurally optimized inhibitors aim to reprogram leukemic cells rather than kill them.

Parse Score

28.7
Strength2/ 100
Reach26/ 100
Authority0/ 100

Work at CHARM Therapeutics?

Claim this profile for the full report: every prompt where CHARM Therapeutics appears, who is gaining, and what AI says about you. Claiming is free. Ongoing monitoring is a paid upgrade.

Verified with a work email.

Always know where you stand in AI

Monitor CHARM Therapeutics